“One Health” concept is a worldwide strategy characterized by promoting the integration of human, animal, and environmental health through cross-disciplinary, cross-sectoral, cross-regional communication, and collaboration, aiming to improve health and well-being through the prevention of risks and the mitigation of effects of crises [1]. There was a worldwide consensus on implementing the “One Health” strategy, emphasizing its ability to sustainably improve the health of humans, animals, and ecosystems. “One Health” strategy is critical for tackling modern challenges such as emerging zoonotic diseases, food safety, climate change, and antimicrobial resistance. What's more, animal welfare is an essential part of the “One Health” framework, with animal and human health and the environment being interconnected [2].
Annually, the health of untold millions of lives around the world are threatened by existing or novel emerging zoonotic diseases. Emerging or re-emerging of the zoonotic infectious diseases is suggested to be promoted by increasing human–animal contacts, international trade of animals, and the expansion of global travel [3]. The transmission and epidemic of zoonotic diseases is a dynamic process, which is jointly affected by all relevant links among humans, animals, and environment, forming a complex network. Given the more and more serious and complex epidemic of zoonotic diseases that have become a globally substantial risk to the health of animals and humans, it is clear that the “One Health” concept must be addressed for combating emerging zoonotic diseases at the human–animal–environment interface. When the practice of “One Health” concept is properly implemented, it will be an effective strategy to tackle zoonotic diseases. The European Union and the United States have provided funding to support interdisciplinary research within the “One Health” strategy, such as research on interventions for emerging zoonotic diseases and early warning systems of threats to humans from animals [4]. It is reported that investing in the “One Health” concept to mitigate pandemics by reducing the impact of their underlying drivers are likely to be more effective than business as usual, saving over $300 billion worldwide over the next century [5]. A five-step framework, “Generalizable One Health Framework (GOHF)”, was developed by the US Centers for Disease Control and Prevention (CDC) and Food and Agriculture Organization of the United Nations (FAO), which provides structure for using the “One Health” approach in zoonotic disease programs being implemented in technical domains including laboratory, surveillance, joint outbreak response, prevention and control, preparedness, communication, and government and policy at the local, sub-national, national, regional, or international level [6]. In China, the “One Health” concept is gaining recognition as an effective way
Mpox, formerly known as monkeypox, is a zoonotic disease caused by the monkeypox virus (MPXV), which belongs to the genus Orthopoxvirus of the family Poxviridae. It is an enveloped brick-shaped virus with a double-stranded DNA genome of approximately 200,000 bp in length that has two distinct genetic clades: clade I (Ia and Ib) endemic to Central Africa, usually in the Congo, and clade II (IIa and IIb) endemic to West Africa [1]. These two clades showed different patterns of transmission and disease severity. Clade I has a higher potential for human-to-human transmission, mostly through men-to-men sexual contact, and causes severe outcomes with approximately 10% mortality among those infected [2]. In contrast, clade II is less infectious, causes less severe disease, and has a lower mortality rate, around 1%, but has demonstrated the ability to spread more efficiently to nonendemic areas. Since its discovery, Mpox has been associated with small-scale endemic outbreaks in West and Central Africa. However, the number of outbreaks has recently increased. An outbreak of clade II has spread worldwide since May 2022, and the World Health Organization (WHO) declared it a Public Health Emergency of International Concern (PHEIC) on July 23, 2022. As of October 25, 2023, more than 91,328 Mpox infections have been reported in 116 countries with 170 deaths [3]. Another outbreak of clade Ib began in the Democratic Republic of the Congo (DRC) in December 2023 and spread to neighboring states such as Burundi, Kenya, Rwanda, and Uganda. From 2023 to 29 March 2024, the DRC reported 18,922 Mpox cases, including 1007 deaths [4]. As of 14 August 2024, an additional 15,600 confirmed cases and 537 deaths [5], and as of 5 January 2025, another 4058 confirmed cases and 13 deaths [6] were reported.
Vaccines, notably smallpox vaccines, offer protection against Mpox infection. In contrast, in a recent study, mRNA-1769 showed superior preclinical efficacy in reducing symptoms and viral replication compared to modified vaccinia Ankara (MVA) in monkeys, highlighting potential healthcare strategies against future Mpox epidemics as a scalable, safe, and effective alternative vaccine [7]. This commentary discussed the progress in developing mRNA vaccines as a promising healthcare strategy against Mpox.
The MPXV genome is closely related to other members of the Orthopoxvirus, ranging from the most virulent, variola virus (which causes smallpox) to the less virulent, vaccinia virus (VACV). Vaccines produced from one member of the genus confer immunity against another member. The U.S. Strategic National Stockpile contains several conventional vaccines against smallpox: Aventis Pasteur Smallpox Vaccine (APSV), ACAM2000, JYNNEOS, and LC16m8. Although these vaccines were highly effective, providing lifelong immunity and playing a key role in eradicating smallpox, the APSV and ACAM2
The dynamic interaction between the gut microbiota and the host significantly affects host biological processes and disease progression. In recent years, the regulatory mechanisms underlying these intricate interactions have been widely studied. Noncoding RNAs (ncRNAs) are a class of functional RNAs that, despite not being translated into proteins, play critical roles in mediating host–gut microbiota interactions. In this review, we systematically elucidate the mechanisms of action and influence of ncRNAs derived from both hosts and microorganisms. Specifically, certain host ncRNAs depend on the microbiota to modulate gene expression and function, whereas other host ncRNAs can alter the composition and functionality of the gut microbiota. Conversely, bacterial small RNAs (sRNAs) can infiltrate host cells and modulate the expression and functions of host genes. These interactions reveal the complex communication modes between the host and microbiota, providing a new perspective for investigating the occurrence and development of intestinal diseases. Consequently, through the intervention of ncRNAs, host‒microbe interaction dynamics can be effectively regulated, thereby providing potential theoretical and technical foundations for the prevention and treatment of intestinal diseases.
Salmonella Pullorum is a host-restricted pathogen that causes substantial economic losses in the poultry industry. This study explores the genomic characteristics of S. Pullorum based on the genomes available on GenBank, with a particular focus on its evolution and antibiotic resistance in China. The analysis reveals that most S. Pullorum strains belong to ST92 and ST2151. The S. Pullorum strains harbor a complex repertoire of virulence genes and nine antibiotic resistance genes (ARGs), including aminoglycoside resistance genes aac (6′)-Iaa, aadA5, aph (3″)-Ib, and aph (6)-Id; the tetracycline resistance gene tet(A); sulfonamide resistance genes dfrA17, sul1, and sul2; and the beta-lactam resistance gene blaTEM-1B. The IncX1, IncQ1, and IncN plasmids play significant roles in the co-transmission of these ARGs. In addition, phylogenetic analysis indicates a closer genetic relationship among S. Pullorum strains isolated from the same country, highlighting the potential regional transmissions. Notably, S. Pullorum strains in China carry a higher number of ARGs than strains from other countries. Evolutionary dynamics reveals that the population size of S. Pullorum in China has stabilized since 2016, while the antibiotic resistance continues to rise. These results underscore the growing risk of S. Pullorum to the poultry industry and public health in China, highlighting the need for ongoing surveillance and effective control measures.
China boasts an abundance of indigenous chicken genetic resources, where the exploitation of whole-genome single nucleotide polymorphism (SNP) information offers significant potential for their development. However, the current chicken SNP chips are primarily designed for commercial chickens or a few local breeds. To address this gap, we have developed “Shennong 1 chicken 40K” liquid chip utilizing the genotyping by targeted sequencing. This chip integrates SNPs and present/absent variants and is specifically crafted for Chinese indigenous chickens. It encompasses 44,849 target sites, selected through an integration of whole-genome resequencing data, pan-genome data, genome-wide association study data, and previously reported functional data for economic traits. Compared to published gene chips, this chip contains a higher number of polymorphic loci in Chinese indigenous chickens, demonstrating enhanced applicability. Our validation of the chip on 204 individuals from seven different breeds yielded a mean capture ratio of 99.474% for the target sites, with minor allele frequencies > 0.05 accounting for 98.557% of the total sites. This chip effectively classifies different breeds, aligning clustering results from population structure analysis with actual breed groupings, thereby demonstrating the chip's excellent applicability. Additionally, we identified genes associated with production and environmental adaptation in chickens through selection signal analysis (IGF1, SOX5, CACNA1G, and CXCR4). Importantly, the chip's functional sites allow for precise evaluation, aiding in understanding the economic traits of specific breeds for informed decision-making. Overall, the chip provides essential technical support for the conservation, breeding, identification, and evaluation of Chinese indigenous chicken genetic resources.
Honey bees occupy a pivotal role in safeguarding ecological balance and bolstering the global agricultural economy through their indispensable pollination services. As the foremost commercial pollinator and producer of bee products, the western honey bees, Apis mellifera, have been extensively domesticated and managed worldwide. To harness their potential and enhance production traits, selective breeding practices are commonly implemented under human management. Nevertheless, despite the significance of these efforts, the foundational theories and concepts that underpin honey bee breeding remain fragmented. In this paper, we discuss the biological taxonomy of A. mellifera and the pertinent issues therein, emphasizing the necessity to recognize it as a domesticated animal and elucidate the concepts associated with livestock breeding. Drawing upon recent advances in the studies of honey bees and other domesticated species, we review the progress and challenges encountered in utilizing traditional breeding methods, which rely on phenotypic selection and natural mating, as well as marker-assisted selections integrating modern biotechnological tools at the molecular level. Moreover, the utilization of gene-editing tools in honey bee breeding is prospected, and the importance of reconciling bee breeding practices with conservation strategies is highlighted. Future research endeavors are anticipated to decipher the intricate genetic architecture underlying honey bee traits and develop precise genetic markers while weighing the ecological consequences of these breeding interventions. Through interdisciplinary collaboration and relentless innovation, robust technological support can be established to restore and protect honey bee populations, thereby ensuring the sustained vitality and contribution of this precious natural resource to our planet.

